Operating Lease, Right-of-Use Asset in USD of CYTOKINETICS INC from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CYTOKINETICS INC quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q3 2025.
  • CYTOKINETICS INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $77,580,000, a 1.6% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

CYTOKINETICS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $77,580,000 +$1,236,000 +1.6% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $76,120,000 -$1,129,000 -1.5% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $77,439,000 -$731,000 -0.94% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $75,158,000 -$3,829,000 -4.8% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $76,344,000 -$3,585,000 -4.5% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $77,249,000 -$3,617,000 -4.5% 30 Jun 2024 10-Q 09 Aug 2024 2024 Q2
Q1 2024 $78,170,000 -$3,632,000 -4.4% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $78,987,000 -$3,750,000 -4.5% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $79,929,000 +$4,853,000 +6.5% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $80,866,000 +$8,705,000 +12% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $81,802,000 +$9,156,000 +13% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $82,737,000 +$9,599,000 +13% 31 Dec 2022 10-K 28 Feb 2024 2023 FY
Q3 2022 $75,076,000 -$5,649,000 -7% 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 $72,161,000 -$10,845,000 -13% 30 Jun 2022 10-Q 05 Aug 2022 2022 Q2
Q1 2022 $72,646,000 -$7,041,000 -8.8% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 $73,138,000 +$70,214,000 +2401% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $80,725,000 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $83,006,000 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 $79,687,000 31 Mar 2021 10-Q 07 May 2021 2021 Q1
Q4 2020 $2,924,000 31 Dec 2020 10-K 25 Feb 2022 2021 FY
Q4 2018 $9,600,000 01 Jan 2019 10-K 26 Feb 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.